Torrent Pharmaceuticals Ltd — Rivaroxaban Exporter Profile
Indian Pharmaceutical Exporter · #7 for Rivaroxaban · $2.1M export value · DGFT Verified
Torrent Pharmaceuticals Ltd is the #7 Indian exporter of Rivaroxaban with $2.1M in export value and 59 verified shipments. Torrent Pharmaceuticals Ltd holds a 4.0% market share in Rivaroxaban exports across 5 countries.
Torrent Pharmaceuticals Ltd — Rivaroxaban Export Profile: Buyers & Destinations
Where Does Torrent Pharmaceuticals Ltd Export Rivaroxaban?
| Country | Value | Shipments | Share |
|---|---|---|---|
| BRAZIL | $980.6K | 32 | 50.0% |
| AUSTRALIA | $822.8K | 22 | 41.9% |
| SOUTH AFRICA | $81.4K | 2 | 4.2% |
| ZIMBABWE | $76.6K | 8 | 3.9% |
| GERMANY | $83 | 7 | 0.0% |
Torrent Pharmaceuticals Ltd exports Rivaroxaban to 5 countries. The largest destination is BRAZIL accounting for 50.0% of Torrent Pharmaceuticals Ltd's Rivaroxaban shipments, followed by AUSTRALIA (41.9%) and SOUTH AFRICA (4.2%). These destinations reflect Torrent Pharmaceuticals Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Rivaroxaban from Torrent Pharmaceuticals Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| TORRENT DO BRASIL LTDA | BRAZIL | $591.5K | 20 |
| ARROW PHARMACEUTICALS PTY LTD | AUSTRALIA | $361.8K | 11 |
| ARROW PHARMACEUTICALS PTY LTD. | AUSTRALIA | $332.0K | 8 |
| TORRENT DO BRASIL LIMITEDA | BRAZIL | $204.5K | 5 |
| TORRENT DO BRASIL LTDA, | BRAZIL | $184.6K | 7 |
| ARROW PHARMACEUTICALS PTY LTD. . | AUSTRALIA | $129.0K | 3 |
| TRINITY PHARMA PTY LTD | SOUTH AFRICA | $81.4K | 2 |
| PHARMACEUTICAL & CHEMICAL DISTRIBUT | ZIMBABWE | $42.3K | 3 |
| PHARMACEUTICAL AND CHEMICAL DISTRIB | ZIMBABWE | $22.4K | 3 |
| PHARMACEUTICAL AND CHEMICALS DISTRI | ZIMBABWE | $8.2K | 1 |
Torrent Pharmaceuticals Ltd supplies Rivaroxaban to 12 buyers globally. The largest buyer is TORRENT DO BRASIL LTDA (BRAZIL), followed by ARROW PHARMACEUTICALS PTY LTD (AUSTRALIA) and ARROW PHARMACEUTICALS PTY LTD. (AUSTRALIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Rivaroxaban Export Value and How Much Does Torrent Pharmaceuticals Ltd Contribute?
India exported $36.7M worth of Rivaroxaban through 5,361 shipments from 221 suppliers to 115 countries, serving 497 buyers globally. Torrent Pharmaceuticals Ltd contributes $2.1M to this total, accounting for 4.0% of India's Rivaroxaban exports. Torrent Pharmaceuticals Ltd ships Rivaroxaban to 5 countries through 12 buyers.
What Is the Average Shipment Value for Torrent Pharmaceuticals Ltd's Rivaroxaban Exports?
Torrent Pharmaceuticals Ltd's average Rivaroxaban shipment value is $35.8K per consignment, based on 59 shipments totaling $2.1M. The largest destination is BRAZIL (50.0% of Torrent Pharmaceuticals Ltd's Rivaroxaban exports).
How Does Torrent Pharmaceuticals Ltd Compare to Other Indian Rivaroxaban Exporters?
Torrent Pharmaceuticals Ltd ranks #7 among 221 Indian Rivaroxaban exporters with a 4.0% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($12.8M), DR.REDDY'S LABORATORIES LTD ($5.2M), ZENTIVA PRIVATE LIMITED ($3.2M). Torrent Pharmaceuticals Ltd processed 59 shipments to 5 destination countries.
What Rivaroxaban Formulations Does Torrent Pharmaceuticals Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| ARX-RIVAROXABAN 20 TABLETS (RIVAROXABANTABLETS 20 MG) (NOS = 2X14 TAB.) | $146.2K | 3 |
| ARX-RIVAROXABAN 15 TABLETS (RIVAROXABAN TABLETS 15 MG) (NOS = 2 X 14TAB) | $129.0K | 3 |
| OTHER-ACOG 15 MG TABLETS ( RIVAROXABAN 15 MG TABLETS ) NOS SIZE 3 X 10 TABLETS | $108.4K | 3 |
| OTHER-RIVAROXABAN 20 MG TABLET RIVAROXA | $100.0K | 2 |
| ARX-RIVAROXABAN 20 TABLETS(RIVAROXABAN TABLET 20MG)BSG9M003(20400 PACKS) | $93.5K | 2 |
| ARX-RIVAROXABAN 20 TABLETS (RIVAROXABANTABLETS 20MG)B.NO.BSG9L010,MFG:DEC-2024,EXP:NOV-2027 | $90.9K | 2 |
| OTHER - ACOG 15MG TABLETS (RIVAROXABAN 1 | $77.0K | 2 |
| OTHER-RIVAROXABAN 10 MG TABLET RIVAROXA | $74.1K | 2 |
| ARX-RIVAROXABAN 15 TABLETS(RIVAROXABAN TABLET 15MG)BSG7M001(22704 PACKS) | $71.6K | 2 |
| OTHER-RIVAROXABAN 20MG TABLET (RIVAROXAB | $50.0K | 1 |
Torrent Pharmaceuticals Ltd exports 57 distinct Rivaroxaban formulations including tablets, capsules, syrups, and combination drugs. The top formulation is ARX-RIVAROXABAN 20 TABLETS (RIVAROXABANTABLETS 20 MG) (NOS = with 3 shipments worth $146.2K.
Regulatory Requirements: Exporting Rivaroxaban to Key Markets
What Torrent Pharmaceuticals Ltd must comply with to export Rivaroxaban to its top destination countries
Brazil — ANVISA
Approval Process
Generic registration under RDC 200/2017. ANVISA GMP inspection of Indian facility mandatory before approval.
Timeline: 12–24 months
GMP & Export Requirements
ANVISA GMP certificate (CBPF) for each manufacturing site; on-site inspection by ANVISA
Certificate of Pharmaceutical Product from CDSCO; Import Authorization via SISCOMEX
Note: ANVISA maintains active Indian pharma facility inspection program. Inspection backlog can extend timelines.
Australia — TGA
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
South Africa — SAHPRA
Approval Process
Registration under SAHPRA guidelines (CTD format). Bioequivalence required for generics.
Timeline: 24–48 months (significant backlog)
GMP & Export Requirements
WHO GMP or PIC/S GMP compliance
Certificate of Pharmaceutical Product from CDSCO; Import permit per Section 22A of Medicines Act
Note: Known registration backlog. WHO Prequalification significantly assists the process.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Torrent Pharmaceuticals Ltd Compare to Nearest Rivaroxaban Exporters?
Exporters ranked immediately above and below #7 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | MICRO LABS LIMITED | $2.4M | 141 | 20 | $16.9K |
| 6 | APOTEX RESEARCH PRIVATE LIMITED | $2.3M | 54 | 1 | $42.1K |
| 7 | TORRENT PHARMACEUTICALS LTD ★ | $2.1M | 59 | 5 | $35.8K |
| 9 | INTAS PHARMACEUTICALS LIMITED | $1.6M | 165 | 13 | $9.9K |
| 10 | ALEMBIC PHARMACEUTICALS LIMITED | $1.3M | 38 | 7 | $33.5K |
Torrent Pharmaceuticals Ltd ranks #7 among 221 Indian Rivaroxaban exporters. Average shipment value of $35.8K compared to the market average of $166.0K. The closest competitors by value are MICRO LABS LIMITED and APOTEX RESEARCH PRIVATE LIMITED.
Which Indian Ports Ship Rivaroxaban Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 1,144 | 21.3% |
| DELHI AIR CARGO ACC (INDEL4) | 985 | 18.4% |
| DELHI AIR | 659 | 12.3% |
| SAHAR AIR CARGO ACC (INBOM4) | 635 | 11.8% |
| Bombay Air | 197 | 3.7% |
| NHAVA SHEVA SEA (INNSA1) | 164 | 3.1% |
| Delhi Air | 133 | 2.5% |
| HYDERABAD AIR | 110 | 2.1% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Rivaroxaban — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Rivaroxaban shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Torrent Pharmaceuticals Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 71 individual customs records matching Torrent Pharmaceuticals Ltd exporting Rivaroxaban, covering 57 formulations to 5 countries via 12 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 115+ countries, 497+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Rivaroxaban Export Data from Torrent Pharmaceuticals Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Torrent Pharmaceuticals Ltd's Rivaroxaban exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Torrent Pharmaceuticals Ltd
Company Profile
0 products · $0 total trade · 0 categories
Rivaroxaban Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Torrent Pharmaceuticals Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Rivaroxaban. For current shipment-level data, contact TransData Nexus.